Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features

Lung Cancer

Volumn 45, Issue 3, 2004, Pages 349-355

  Pentheroudakis, G ^a   Kostadima, L ^a   Fountzilas, G ^b   Kalogera Fountzila, A ^c   Klouvas, G ^d   Kalofonos, C ^e   Pavlidis, N ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Henry Dunnan Hospital   (Greece)

^e Department of Medical Oncology   (Greece)

Author keywords

Cavitation; Lung cancer; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CAVITATING SQUAMOUS CELL LUNG CARCINOMA; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DISEASE DURATION; FEMALE; FEVER; HUMAN; INTERMETHOD COMPARISON; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; VASCULAR DISEASE; WEIGHT REDUCTION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 3843052570     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.02.013     Document Type: Article

References (14)

1. Berger M., Thompson J.R. Cavitary carcinomatosis of the lungs. Dis. Chest. 52:1967;106-111
2. Chaudhuri M.R. Primary pulmonary cavitating carcinomas. Chest. 28:1973;354-366
3. Feigin M.I., Giaurgiewa O.K.H., Kicha M.G., Knoring B.E., Khaeva S.K.H., Rapis I.L. Current principles of cavitary formations in the lungs. Probl. Tuberk. 7/8:1992;13-15
4. Miller R.R., McGregor D.H. Hemorrhage from carcinoma of the lung. Cancer. 46:1980;200-205
5. Kolodziejski L.S., Dyczek S., Duda K., Góralczyk J., Mysocki W.M., Lobaziewicz W. Cavitated tumor as a clinical subentity in squamous cell lung cancer patients. Neoplasma. 1:2003;66-73
6. Good C.A., Holman C.B. Cavitary carcinoma of the lung; roentgenologic features in 19 cases. Dis. Chest. 37:1960;289-293
7. Heelan R.T., Martini N., Westcott J.W., Bains M.S., Watson R.C., Caravelli J.F., et al. Carcinomatous involvement of the hilum and mediastinum; computed tomographic and magnetic resonance evaluation. Radiology. 156:1985;111-115
8. Bernard W.F., Malcolm J.A., Wylie R.H. The carcinomatous abscess: a clinical paradox. N. Engl. J. Med. 266:1962;914-919
9. Peters F.P.J., Thunnissen F.B., ten Velde G.P.M. Pulmonary cavitating squamous cell carcinoma. J. Clin. Oncol. 1:1998;363-364
10. Miura H., Taira O., Hiraguri S., Hagiwara M., Kato H. Cavitating adenocarcinoma of the lung. Ann. Thorac Cardiovasc. Surg. 4:1998;154-158
11. Geddes D.M. The natural history of lung cancer. A review based on rates of tumour growth. Br. J. Dis. Chest. 73:1979;1-17
12. Mountain C.F. Surgical treatment of lung cancer. Clin. Rev. Oncol./Hematol. 11:1991;179-207
13. Mouroux J., Padovani B., Elkaim D., Richelme H. Should cavitated bronchopulmonary cancers be considered a separate entity? Ann. Thorac. Surg. 61:1996;530-532
14. Janot F., Cvitkovic E., Piekarski J.D., Sigal R., Armand J.P., Bensmaine L.B. Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: a prospective validation. Head Neck. 15(3):1993;222-229